Current Eurasian ASFV strain levels of maximum viraemia in blood and shedding potential in other body fluids after various modes of inoculation
| Maximum viraemia | ||||||
|---|---|---|---|---|---|---|
| Inoculation mode | ASFV strain | Dose HAD50/(mL) | Titre (log10 HAD50/mL) | Dpi | Virus detection in other body secretions/excretions | Reference |
| Georgia 2007/1 | 102 | 6–8 | 5 | Nasal fluid: VI+ (102–104), 5 dpi Rectal fluid: (10–102), 6 dpi Urine: Excretions: PCR+*, PCR+*, VI+ VI+ Oral fluid: PCR+*, VI− *1st day of fever | Guinat.et al. (21), 2014 | |
| Intramuscular | Lithuania LT14/1490 | 101 | 6.4–8.7 | 6 | n/a | Gallardo.et al. (17), 2015 |
| 5 × 103 | 6.5–7 | 7 | Nasal fluid: PCR+ | |||
| Russia K/08/13 | 50 | 6.5–7 | 9 | Rectal fluid: PCR+ | Vlasova.et al. (48), 2015 | |
| Georgia 2007/1 | 103 | 7–8 | 7 | n/a | O’Donnell.et al. (34), 2016 | |
| Odintsovo 02/14 | 5 × 103 | 7.56 | 11 | n/a | Elsukova.et al. (14), 2017 | |
| Caucasian | 2 × 106 | Cq: 22–39 | 5 | Oropharyngeal Faecal fluid: PCR+, fluid: 5 PCR+, dpi 6 dpi | Blome.et al. (2), 2013 | |
| 5 × 103 | 7.5 | 7 | ||||
| Kashino 04/13 | 50 | 6.5–7.5 | 7 | Nasal fluid: PCR+ | ||
| 5 × 103 | 6.5–7.5 | 9 | Rectal fluid: PCR+ | Vlasova.et al. (48), 2015 | ||
| Boguchary 06/13 | 50 | 6.5–7 | 5 | |||
| Oral/nasal | Pol/15/Lindholm | 2 × 104 | ~9 | 6 | Nasal fluid: PCR+*, VI+ (101.6–4.8) Rectal fluid: PCR+*, VI+ (102.8–3) Oral fluid: PCR +*, VI− *1st day of fever Viral isolation at day of euthanasia | Olesen.et al. (38), 2017 |
| Odintsovo 02/14 | 103 | 7.45 | 11 | n/a | Elsukova.et al. (14), 2017 | |
| 50 | 7.45 | 27 | ||||
| Caucasian | n/a | Cq: 20–29 | 11 | n/a | Blome.et al. (2), 2013 | |
| Georgia 2007/1 | n/a | 6–8 | 10 | Nasal rectal fluid: fluid: VI+ VI+ ((1010––101022) ) from from 7 12 dpi, dpi | Guinat.et al. (21), 2014 | |
| Kashino 04/13 | n/a | 6.5–7 | 15 | n/a | ||
| Boguchary 06/13 | n/a | 7 | 9 | n/a | Vlasova.et al. (48), 2015 | |
| Contact | Lithuania LT14/1490 | n/a | 6.4–8.7 | 14 | n/a | Gallardo.et al. (17), 2015 |
| Odintsovo 02/14 | n/a | 7.45–7.66 | 29 | n/a | Elsukova.et al. (14), 2017 | |
| Pol/15/Lindholm | n/a | ~9 | 12 | Nasal fluid: PCR+, VI+ (101.8–2.8) Rectal fluid: PCR+, VI+ (101.6–8) Oral fluid: VI− PCR + in many prior to the PCR+ from blood | Olesen.et al. (38), 2017 | |